What You Should Know:
- Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better outcomes for clinical trials globally.
- Jumo Health develops creative, patient-centric educational solutions that improve health literacy to accelerate clinical trial enrollment and increase participant
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought to market. This transformation is not just limited to the research and development phases; AI is also playing a critical role in ensuring that drugs meet regulatory standards.
The AI Revolution in Drug Discovery
Drug discovery has traditionally been a
Read More
Reliant AI Emerges from Stealth with $11.3M for GenAI Biopharma Data Analysis
What You Should Know:
- Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi, the investment will fuel the company's growth and expansion.
- Founded by a team of leading experts in natural language processing and reinforcement learning with backgrounds at DeepMind, Google Brain, and EY
Read More
Accenture Invests in Earli Inc. for Early Cancer Detection
What You Should Know:
- Accenture today announced a strategic investment in Earli Inc., a biotechnology company pioneering a novel approach to early cancer detection.
- Earli’s groundbreaking technology aims to transform cancer diagnosis and treatment by enabling the rapid and accurate identification of cancerous cells.
Synthetic Targeting Platform for Early Cancer Detection
Earli has developed a synthetic targeting platform that selectively reprograms cancer cells,
Read More
Medable Launches No-Code Platform for Clinical Trials
What You Should Know:
- Medable Inc., the leading technology platform for clinical trials, today announced Medable Studio, an all-in-one application for configuring, translating, validating, and launching eCOA Plus (eCOA, eConsent, Televisit, Sensors) into clinical trials.
- Studio is a no-code suite that simplifies the complex eCOA launch process, giving biopharmaceutical companies greater control and transparency for faster study go-live and earlier patient enrollment. Customers choose
Read More
Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery
What You Should Know:
- Quantiphi, an AI-first digital engineering company, announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator. This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development.
- By combining Quantiphi’s AI expertise with Transcell’s stem cell technology, the partnership aims to accelerate the development of innovative treatments while reducing
Read More
PathAI Introduces AI-Based Measurement for MASH Scoring
What You Should Know:
- PathAI, a leader in AI-powered digital pathology solutions, announced today the launch of AIM-MASH on its AISight Image Management System (IMS).
- The new product offers advanced AI-based measurement tools to support pathologists in assessing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) using the MASH Clinical Research Network (CRN) Activity Score.
AIM-MASH Integration with AISight
By integrating AIM-MASH with AISight, PathAI
Read More
Citeline Launches AI-Powered Tools for Clinical Trials
What You Should Know:
- Citeline, a provider of intelligence solutions for the life sciences industry, today announced the launch of Protocol SmartDesign and Investigator SmartSelect, two new AI-powered tools designed to streamline and optimize clinical trial development.
- These innovative solutions are part of the Citeline SmartSolutions suite, which leverages the company's extensive data assets to deliver actionable insights for life sciences organizations.
How Protocol
Read More
Absci and MSK Collaborate on Generative AI Drug Discovery
What You Should Know:
- Absci Corporation, a leader in generative AI drug creation, today announced a strategic collaboration with Memorial Sloan Kettering Cancer Center (MSK) to develop up to six novel cancer therapeutics.
- By combining Absci’s AI platform with MSK’s renowned cancer research expertise, the partnership aims to accelerate the discovery and development of new treatments for this devastating disease.
Absci's Integrated Drug Creation Platform
Absci's Integrated
Read More
SVB Report: 2024 Mid-Year Healthcare Investments and Exits
What You Should Know:
- The healthcare venture capital landscape experienced a resurgence in the first half of 2024, according to a new report from Silicon Valley Bank (SVB). Despite ongoing economic challenges, 89% of US VC funds exceeding $25M successfully met their fundraising targets.
- The report, "2024 Mid-Year Healthcare Investments and Exits," delves into venture capital activity across the healthcare sector, including biopharma, healthtech, medical device, and
Read More
